BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23086544)

  • 1. The current status of an FDG-PET cancer screening program in Japan, based on a 4-year (2006-2009) nationwide survey.
    Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Murano T; Fukuda H; Iinuma T; Uno K; Nishizawa S; Tsukamoto E; Iwata H; Inoue T; Oguchi K; Nakashima R; Inoue T
    Ann Nucl Med; 2013 Jan; 27(1):46-57. PubMed ID: 23086544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance profile of FDG-PET and PET/CT for cancer screening on the basis of a Japanese Nationwide Survey.
    Minamimoto R; Senda M; Uno K; Jinnouchi S; Iinuma T; Ito K; Okuyama C; Oguchi K; Kawamoto M; Suzuki Y; Tsukamoto E; Terauchi T; Nakashima R; Nishio M; Nishizawa S; Fukuda H; Yoshida T; Inoue T
    Ann Nucl Med; 2007 Nov; 21(9):481-98. PubMed ID: 18030580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of various malignant neoplasms detected by FDG-PET cancer screening program: based on a Japanese Nationwide Survey.
    Minamimoto R; Senda M; Terauchi T; Jinnouchi S; Inoue T; Iinuma T; Inoue T; Ito K; Iwata H; Uno K; Oku S; Oguchi K; Tsukamoto E; Nakashima R; Nishizawa S; Fukuda H; Murano T; Yoshida T
    Ann Nucl Med; 2011 Jan; 25(1):45-54. PubMed ID: 20953985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of thyroid cancer by an FDG-PET cancer screening program: a Japanese nation-wide survey.
    Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Inoue T
    Anticancer Res; 2014 Aug; 34(8):4439-45. PubMed ID: 25075083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of breast cancer in an FDG-PET cancer screening program: results of a nationwide Japanese survey.
    Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Inoue T
    Clin Breast Cancer; 2015 Apr; 15(2):e139-46. PubMed ID: 25454690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of colorectal cancer and adenomas by FDG-PET cancer screening program: results based on a nationwide Japanese survey.
    Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Inoue T
    Ann Nucl Med; 2014 Apr; 28(3):212-9. PubMed ID: 24347363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance profile of a FDG-PET cancer screening program for detecting gastric cancer: results from a nationwide Japanese survey.
    Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Inoue T
    Jpn J Radiol; 2014 May; 32(5):253-9. PubMed ID: 24562822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of lung cancer by FDG-PET cancer screening program: a nationwide Japanese survey.
    Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Uno K; Iinuma T; Murano T; Nakashima R; Inoue T
    Anticancer Res; 2014 Jan; 34(1):183-9. PubMed ID: 24403460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Performance profile of FDG-PET and PET/CT for cancer screening based on a Japanese nationwide survey].
    Minamimoto R; Senda M; Uno K; Jinnouchi S; Iinuma T; Ito K; Okuyama C; Oguchi K; Kawamoto M; Suzuki Y; Tsukamoto E; Terauchi T; Nakashima R; Nishio M; Nishizawa S; Fukuda H; Yoshida T; Inoue T
    Kaku Igaku; 2007 May; 44(2):105-24. PubMed ID: 18240583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of FDG-PET cancer screening in asymptomatic individuals: use of record linkage from the Osaka Cancer Registry.
    Sengoku T; Matsumura K; Usami M; Takahashi Y; Nakayama T
    Int J Clin Oncol; 2014 Dec; 19(6):989-97. PubMed ID: 24481919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of whole-body cancer screening using 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography: a preliminary report.
    Terauchi T; Murano T; Daisaki H; Kanou D; Shoda H; Kakinuma R; Hamashima C; Moriyama N; Kakizoe T
    Ann Nucl Med; 2008 Jun; 22(5):379-85. PubMed ID: 18600415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic role of 18F-fluorodeoxyglucose positron emission tomography for follicular lymphoma with gastrointestinal involvement.
    Iwamuro M; Okada H; Takata K; Shinagawa K; Fujiki S; Shiode J; Imagawa A; Araki M; Morito T; Nishimura M; Mizuno M; Inaba T; Suzuki S; Kawai Y; Yoshino T; Kawahara Y; Takaki A; Yamamoto K
    World J Gastroenterol; 2012 Nov; 18(44):6427-36; discussion p.6434. PubMed ID: 23197888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer screening using 18F-FDG PET/CT in Korean asymptomatic volunteers: a preliminary report.
    Lee JW; Kang KW; Paeng JC; Lee SM; Jang SJ; Chung JK; Lee MC; Lee DS
    Ann Nucl Med; 2009 Sep; 23(7):685-91. PubMed ID: 19662344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG-PET/CT detection of very early breast cancer in women with breast microcalcification lesions found in mammography screening.
    Peng NJ; Chou CP; Pan HB; Chang TH; Hu C; Chiu YL; Fu TY; Chang HT
    J Med Imaging Radiat Oncol; 2015 Aug; 59(4):445-452. PubMed ID: 25872026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer screening with FDG-PET.
    Ide M
    Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):23-7. PubMed ID: 16557201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation exposure and risk-benefit analysis in cancer screening using FDG-PET: results of a Japanese nationwide survey.
    Murano T; Minamimoto R; Senda M; Uno K; Jinnouchi S; Fukuda H; Iinuma T; Tsukamoto E; Terauchi T; Yoshida T; Oku S; Nishizawa S; Ito K; Oguchi K; Kawamoto M; Nakashima R; Iwata H; Inoue T
    Ann Nucl Med; 2011 Nov; 25(9):657-66. PubMed ID: 21720777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of prostate cancer by an FDG-PET cancer screening program: results from a Japanese nationwide survey.
    Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Inoue T
    Asia Ocean J Nucl Med Biol; 2014; 2(1):19-23. PubMed ID: 27408855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body
    Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
    Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.